Vaginal health products

• US 7,485,666 B2
• Filed: 06/17/2004
• Issued: 02/03/2009
• Est. Priority Date: 06/17/2004
• Status: Expired due to Fees

• Current Assignee: Kimberly-Clark Worldwide Incorporated (Kimberly-Clark Corporation)
• Original Assignee: Kimberly-Clark Worldwide Incorporated (Kimberly-Clark Corporation)
• Inventors: Malik, Sohail, Villanueva, Julie M.
• Primary Examiner(s): Padmanabhan; Sreeni
• Assistant Examiner(s): Carter; Kendra D
• Application Number:
  US10/872,194
• Publication Number:
  US 20050282835A1
• Time in Patent Office: 1,692 Days
• Field of Search: 514/458, 514/468, 514/675, 514/715, 514/763, 514/784, 514/785, 514/967
• US Class Current: 514/458
• CPC Class Codes: A61K 2300/00 Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
• CPC Class Codes: A61K 31/19 Carboxylic acids, e.g. valproic acid salicylic acid A61K31/60
• CPC Class Codes: A61K 31/355 Tocopherols, e.g. vitamin E
• CPC Class Codes: A61K 31/365 Lactones
• CPC Class Codes: A61P 15/02 for disorders of the vagina

Abstract

The invention provides compositions and methods for increasing cell growth, stimulating cell turnover and promoting the secretion of mucus within the reproductive tract of a female mammal.

Claims

1. A method for increasing growth of epithelial or epidermal cells in a vaginal cavity of a female comprising administering to the vaginal cavity an effective amount of a composition comprising a carrier, vitamin E, and jasmonic acid.

2. The method of claim 1, wherein the composition further comprise a retinoid or carotenoid.

3. The method of claim 2, wherein the composition increases expression of estrogen receptor alpha (ER-α

), vascular endothelial growth factor or P2Y₂ receptor.

4. The method of claim 1, wherein the composition further comprises a nucleotide, wherein the nucleotide is ATP.